郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

病毒感染A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters.

期刊：Vaccine发表年份：2024作者：Irene Hoxie; Kirill Vasilev; Jordan J Clark; Kaitlyn Bushfield; Benjamin Francis; Madhumathi Loganathan; John D Campbell; Dong Yu; Lizheng Guan; Chunyang Gu; Shufang Fan; S Mark Tompkins; Gabriele Neumann; Yoshihiro Kawaoka; Florian Krammer
阅读更多 →

病毒感染Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.

期刊：Immunity发表年份：2021作者：Daisy A Hoagland; Rasmus Møller; Skyler A Uhl; Kohei Oishi; Justin Frere; Ilona Golynker; Shu Horiuchi; Maryline Panis; Daniel Blanco-Melo; David Sachs; Knarik Arkun; Jean K Lim; Benjamin R tenOever
阅读更多 →

病毒感染Coxsackievirus A7 and Enterovirus A71 Significantly Reduce SARS-CoV-2 Infection in Cell and Animal Models.

期刊：Viruses发表年份：2024作者：Victor A Svyatchenko; Stanislav S Legostaev; Roman Y Lutkovskiy; Elena V Protopopova; Eugenia P Ponomareva; Vladimir V Omigov; Oleg S Taranov; Vladimir A Ternovoi; Alexander P Agafonov; Valery B Loktev
阅读更多 →

病毒感染The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.

期刊：Virology发表年份：2021作者：Charles B Stauft; Christopher Z Lien; Prabhuanand Selvaraj; Shufeng Liu; Tony T Wang
阅读更多 →